Board approved scheduled medicines list for endorsed optometrists

Registration Standards

Guidelines for use of scheduled medicines: Appendix B

Below is the Board-approved list of topical schedule 2,3 and 4 medicines that optometrists with a scheduled medicines endorsement are qualified to administer, obtain, possess, prescribe, supply or use for the purposes of the practice of optometry, found in Appendix B of the Board’s Guidelines for use of scheduled medicines.¹

This list is effective as of 10 December 2021 and should be read in conjunction with the Endorsement for scheduled medicines registration standard and Guidelines for use of scheduled medicines.

Download the PDF version effective from 10 December 2021

Schedule 2 Pharmacy Medicine

Anti-infectives

Decongestants/
anti-allergics

Miotics, mydriatics
and cycloplegics

Dibromopropamidine

Propamidine

Antazoline

Azelastine

Ketotifen

Levocabastine

Lodoxamide

Naphazoline

Pheniramine

Sodium Cromoglycate

Phenylephrine ≤2.5%

Schedule 3 Pharmacist Only Medicine

Anti-infectives

Chloramphenicol

Schedule 4 Prescription Only Medicine
Anti-infectives	Anti-inflammatories	Decongestants/ anti-allergics	Anti-glaucomas
Aciclovir Azithromycin Bacitracin Cephazolin Ciprofloxacin Framycetin Ganciclovir Gentamicin Gramicidin Neomycin Ofloxacin Polymyxin Tetracycline Tobramycin	Cyclosporin Dexamethasone Diclofenac Fluorometholone Flurbiprofen Hydrocortisone Ketorolac Lifitegrast Loteprednol Prednisolone	Olopatadine	Apraclonidine Betaxolol Bimatoprost Brimonidine Brinzolamide Dorzolamide Latanoprost Pilocarpine Tafluprost Timolol Travoprost
Miotics, mydriatics and cycloplegics	Local anaesthetics
Atropine Cyclopentolate Homatropine Pilocarpine Phenylephrine Tropicamide	Amethocaine Lignocaine Oxybuprocaine Proxymetacaine

¹ Registered optometrists with a scheduled medicines endorsement must be familiar and comply with the current requirements in the jurisdictions in which they practice. Advice on the legal requirements in a particular state or territory may be obtained from the relevant authority found at www.tga.gov.au/contacts-stateterritory-drugs-poisons-units. For the safe and effective use of a medicine, endorsed optometrists must also be familiar with TGA approved indications found in the product information. The product information may be found at www.ebs.tga.gov.au. Endorsed optometrists must be familiar with the Black Triangle Scheme and report any adverse events involving listed medicines which are included in the Black Triangle Scheme. Further information may be found at www.tga.gov.au/black-triangle-scheme and guideline section 2.5.